Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers. We do this thanks to a commercial model that aligns incentives (fixed-price quotes per study, with milestone-based payments), marrying a world-class clinical operations team with our unique software platform, and access to 30 million Electronic Health Records. We handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management. We have helped over 40 sponsors run entire clinical studies across the US, UK, and Europe up to 2x faster than traditional CROs.
$55M sweet spot round size
$55M
from 2 investors over 1 rounds
Lindus Health raised $55M on February 22, 2025
Investors: Balderton Capital and + 3 Other investors